- Home
- RMCF vs BCTX Comparison
RMCF vs BCTX Comparison
Compare RMCF & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RMCF | BCTX |
|---|---|---|
| Founded | 1981 | 2014 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.2M | 28.8M |
| IPO Year | 2024 | 2025 |
Fundamental Metrics
Financial Performance| Metric | RMCF | BCTX |
|---|---|---|
| Price | $2.34 | $4.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $40.00 |
| AVG Volume (30 Days) | 38.1K | ★ 195.7K |
| Earning Date | 04-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $30,432,352.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $380.95 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.12 | $0.61 |
| 52 Week High | $2.99 | $14.68 |
Technical Indicators
Market Signals| Indicator | RMCF | BCTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.00 | 46.99 |
| Support Level | $1.47 | $4.10 |
| Resistance Level | $2.60 | $4.42 |
| Average True Range (ATR) | 0.12 | 0.30 |
| MACD | -0.04 | 0.12 |
| Stochastic Oscillator | 13.51 | 63.10 |
Price Performance
Historical ComparisonAbout RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, U-Swirl Operations, and Other t. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.